Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.960
-0.080 (-3.92%)
At close: Aug 14, 2026, 4:00 PM EDT
1.800
-0.160 (-8.16%)
After-hours: Aug 14, 2026, 7:53 PM EDT
Alector Market Cap
Alector has a market cap or net worth of $218.85 million as of August 14, 2026. Its market cap has decreased by -0.81% in one year.
Market Cap
218.85M
Enterprise Value
78.81M
1-Year Change
-0.81%
Ranking
Category
Stock Price
$1.96
ChartMarket Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $218.85M, a decrease of -82.22%. That is a compound annual growth rate of -20.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 218.85M | 28.52% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 228.78M |
| Compugen | 228.29M |
| NovaBridge Biosciences | 226.67M |
| AN2 Therapeutics | 226.04M |
| Atrium Therapeutics | 219.64M |
| Immunic | 219.13M |
| Minerva Neurosciences | 218.68M |
| Tonix Pharmaceuticals Holding | 217.99M |